{
  "url": "https://openlegislation.uk/misuse-of-drugs-regulations-northern-ireland-2002/regulation-18",
  "json_url": "https://openlegislation.uk/misuse-of-drugs-regulations-northern-ireland-2002/regulation-18.json",
  "legislation": "nisr/2002/1",
  "legislation_title": "The Misuse of Drugs Regulations (Northern Ireland) 2002",
  "legislation_url": "https://openlegislation.uk/misuse-of-drugs-regulations-northern-ireland-2002",
  "path": "regulation/18",
  "kind": "regulation",
  "number": "18",
  "heading": "Marking of bottles and other containers",
  "text": "(1) Subject to paragraph (2), no person shall supply a controlled drug otherwise than in a bottle, package or other container which is plainly marked—\n(a) in the case of a controlled drug other than a preparation, with the amount of the drug contained therein;\n(b) in the case of a controlled drug which is a preparation—\n(i) made up into tablets, capsules or other dosage units, with the amount of each component (being a controlled drug) of the preparation in each dosage unit and the number of dosage units in the bottle, package or other container;\n(ii) not made up as aforesaid, with the total amount of the preparation in the bottle, package or other container and the percentage of each of its components which is a controlled drug.\n(2) Nothing in this regulation shall have effect in relation to—\n(a) the drugs specified in Schedules 4 and 5 or poppy-straw;\n(b) any drug specified in Schedule 3 contained in or comprising a preparation which—\n(i) is required for use as a buffering agent in chemical analysis;\n(ii) has present in it both a substance specified in paragraph 1 or 2 of that Schedule and a salt of that substance; and\n(iii) is premixed in a kit;\n(c) any exempt product;\n(d) the supply of a controlled drug by or on the prescription of a practitioner;\n(e) the supply of a controlled drug for administration in a clinical trial or a medicinal test on animals.\n(3) In this regulation, the expressions “clinical trial” and “medicinal test on animals” have the same meanings as in the Medicines Act 1968.",
  "extent": "N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "I",
      "label": "I1",
      "text": "Reg. 18 in operation at 1.2.2002, see reg. 1"
    }
  ],
  "outstanding_effects": [
    {
      "type": "words omitted",
      "affecting": "nisr/2018/173",
      "affecting_title": "The Misuse of Drugs (Amendment No.2) Regulations (Northern Ireland) 2018"
    },
    {
      "type": "substituted",
      "affecting": "uksi/2012/1916",
      "affecting_title": "The Human Medicines Regulations 2012"
    },
    {
      "type": "words inserted",
      "affecting": "nisr/2005/119",
      "affecting_title": "The Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2005"
    },
    {
      "type": "substituted",
      "affecting": "nisr/2012/168",
      "affecting_title": "The Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2012"
    },
    {
      "type": "words inserted",
      "affecting": "nisr/2023/218",
      "affecting_title": "The Misuse of Drugs (Amendment No.2) Regulations (Northern Ireland) 2023"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/nisr/2002/1/regulation/18",
    "retrieved_at": "2026-10-29T02:09:23.249033+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}